Sung Lee Insider Profile
4 Followers
Sung Lee, EVP & CFO at Cytokinetics, holds 63.22K shares in Cytokinetics (Ticker: CYTK), holds 22.87K shares in Tango Therapeutics (Ticker: TNGX), holds 100.49K shares in Vir Biotechnology (Ticker: VIR).
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+10.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sung Lee holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sung Lee
Sung Lee's Trading History
Cytokinetics
Jul 02, 2026
EVP & CFO
Uninformative Buy
53.94K
$4.42M
Tango Therapeutics
Jun 08, 2026
Director
Uninformative Buy
―
$537.22K
Sangamo Therapeutics
Nov 30, 2020
EVP & CFO
Uninformative Sell
49.26K
$12.51K
Vir Biotechnology
Mar 28, 2024
EVP & CFO
Informative Sell
59.36K
$1.10M
List of latest transactions for each holding click on a transaction to see Sung Lee's performance on stock
You May Also Like
Sung Lee insider profile FAQ
What is the percentage of profitable transactions made by Sung Lee?
The percentage of profitable transactions made by Sung Lee is 83%.
What is the average return per transaction made by Sung Lee?
The average return per transaction made by Sung Lee is 10.80%.
What stocks does Sung Lee hold?
Sung Lee holds: CYTK, TNGX, SGMOQ, VIR stocks.
What was Sung Lee’s latest transaction?
Sung Lee latest transaction was an Uninformative Buy of $53.94K.
What was Sung Lee's most profitable transaction?
Sung Lee’s most profitable transaction was an Informative Sell of VIR stock on March 28, 2024. The return on the trade was 33.80%.
What is Sung Lee's role in Cytokinetics?
Sung Lee's role in Cytokinetics is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.